Equanil

Chronic Pain, Anxiety Disorders, Musculoskeletal Diseases

Treatment

20 Active Studies for Equanil

What is Equanil

Meprobamate

The Generic name of this drug

Treatment Summary

Meprobamate is a drug used to reduce anxiety and help people relax. It is mainly used for short-term relief of insomnia, but has largely been replaced by benzodiazepines. In some cases, Meprobamate can also help prevent seizures, although this effect may not work for larger seizures. Meprobamate is a controlled substance in the United States.

Meprobamate

is the brand name

image of different drug pills on a surface

Equanil Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Meprobamate

Meprobamate

1973

18

Effectiveness

How Equanil Affects Patients

Meprobamate is a drug used to reduce anxiety. It used to be the most popular anxiety-relieving drug but has since been replaced by benzodiazepines. It is less likely to make the user feel sleepy compared to similar drugs, but it can make generalized tonic-clonic seizures worse. Meprobamate can also be used as a sleeping aid, but it is only recommended as a last resort.

How Equanil works in the body

Meprobamate works by binding to certain nerve cells in the brain, which leads to calming and pain-relieving effects. Scientists are not sure exactly how it works, but it is believed to act on the thalamus and limbic system of the brain, which are involved in controlling sleep, relaxation, and pain.

When to interrupt dosage

The recommended dosage of Equanil is contingent upon the diagnosed affliction, including Musculoskeletal Diseases, Anxiety Disorders and Chronic Pain. The measure of dosage fluctuates as per the method of administration indicated in the table below.

Condition

Dosage

Administration

Musculoskeletal Diseases

, 400.0 mg, 200.0 mg

, Tablet, Tablet - Oral, Oral

Anxiety Disorders

, 400.0 mg, 200.0 mg

, Tablet, Tablet - Oral, Oral

Chronic Pain

, 400.0 mg, 200.0 mg

, Tablet, Tablet - Oral, Oral

Warnings

Equanil has two contraindications, so it should not be utilized when encountering any of the ailments listed in the following table.

Equanil Contraindications

Condition

Risk Level

Notes

Acute Coryza

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Equanil.

Common Equanil Drug Interactions

Drug Name

Risk Level

Description

Azelastine

Major

Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Azelastine.

Deutetrabenazine

Major

The risk or severity of sedation and somnolence can be increased when Meprobamate is combined with Deutetrabenazine.

Ethanol

Major

Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Ethanol.

Oliceridine

Major

The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Meprobamate is combined with Oliceridine.

Sodium oxybate

Major

Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.

Equanil Toxicity & Overdose Risk

Overdosing on meprobamate can lead to a coma, muscle paralysis, difficulty breathing, shock, fatigue, unresponsiveness, and even death in some cases. A single case study reported a successful survival after consuming 40 g of meprobamate.

image of a doctor in a lab doing drug, clinical research

Equanil Novel Uses: Which Conditions Have a Clinical Trial Featuring Equanil?

358 active trials are presently examining the potential of Equanil to alleviate Chronic Pain, Musculoskeletal Diseases and Anxiety Disorders.

Condition

Clinical Trials

Trial Phases

Anxiety Disorders

49 Actively Recruiting

Phase 2, Not Applicable, Phase 4, Phase 3, Early Phase 1

Musculoskeletal Diseases

2 Actively Recruiting

Not Applicable, Phase 2, Phase 3

Chronic Pain

123 Actively Recruiting

Not Applicable, Phase 2, Phase 4, Phase 3, Early Phase 1, Phase 1

Equanil Reviews: What are patients saying about Equanil?

4.3

Patient Review

1/12/2012

Equanil for Anxious

I've found 200mg of Equinil to be really effective in the past, but I stopped taking it a while ago because I thought it was no longer being manufactured. However, now that I see it's still an option, I'm going to look into getting a prescription again. It leads to much better days after a good night's sleep!
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about equanil

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Equanil a tranquilizer?

"The drug Equanil is a tranquilizer used to treat anxiety for a short amount of time."

Answered by AI

What is Equanil used for?

"This action results in a reduction in anxiety.

This medication is for short-term use to treat anxiety and nervousness. It acts on certain centers in the brain to help calm the nervous system. This leads to a reduction in anxiety."

Answered by AI

Is meprobamate still prescribed?

"Meprobamate is no longer a commonly prescribed medication, but it is still available for purchase. Currently, only generic versions of the drug are available, as all of the brand products have been discontinued."

Answered by AI

What type of drug is Equanil?

"Meprobamate is a medication used to treat anxiety disorders or to provide short-term relief from anxiety symptoms in adults and children aged 6 and older. Meprobamate belongs to a class of medications called tranquilizers. Its mode of action is by slowing down brain activity to induce relaxation."

Answered by AI

Clinical Trials for Equanil

Image of Michael E. DeBakey VA Medical Center, Houston, TX in Houston, United States.

Acceptance and Commitment Therapy for Inflammatory Bowel Disease

18+
All Sexes
Houston, TX

Many Veterans with gastrointestinal disorders, such as inflammatory bowel disease (IBD), also have mental health conditions. IBD and mental health conditions can worsen one another through the brain-gut axis, leading to dramatic deficits in psychosocial functioning and quality of life (QOL). Yet, few Veterans with comorbid IBD and mental health conditions receive psychotherapy and no evidence-based psychotherapies have been tested in Veterans with these comorbidities. Adapting brief acceptance and commitment therapy (ACT) to the specific to the needs of these patients and embedding treatment into routine gastroenterology care may increase Veterans' access to efficient and effective rehabilitative care. This study aims to adapt and test an integrated, 1-Day ACT intervention tailored to the specific needs of Veterans with IBD and mental health conditions to improve psychosocial functioning and QOL.

Waitlist Available
Has No Placebo

Michael E. DeBakey VA Medical Center, Houston, TX

Mackenzie Lynmarie Shanahan, PhD

Image of Cincinnati Urogynecology Associates in Cincinnati, United States.

Nitrous Oxide for Pain During Bladder Botox Injections

18+
Female
Cincinnati, OH

The goal of this clinical trial is to assess if a mix of nitrous oxide and oxygen can improve pain control during bladder Botox injections. The primary question it aims to answer is: Does using nitrous oxide lower the overall level of pain during the procedure? Researchers will compare a 50:50 nitrous oxide/oxygen mixture (administered with the Pro-Nox system) plus standard care (with lidocaine in the bladder) to sham mask plus standard care to see if nitrous oxide works better for lowering pain. Participants will: * Receive their bladder Botox injection in the office setting * Either use nitrous oxide/oxygen plus standard care during the procedure, or sham mask plus standard care * Answer brief questions about pain, anxiety, satisfaction, and willingness to repeat the procedure

Phase 4
Waitlist Available

Cincinnati Urogynecology Associates (+1 Sites)

Image of San Luis Obispo County Juvenile Hall in San Luis Obispo, United States.

Multi-Sensory Therapy for Emotional Dysregulation

12 - 18
All Sexes
San Luis Obispo, CA

Emotional dysregulation in justice-involved youth (JIY) is a condition that significantly impacts young people, their families, and juvenile justice and public health systems. Affecting an estimated 60-70% of detained Attention deficit hyperactivity disorderadolescents, it is a major driver of aggression, substance use, school failure, and later recidivism. Despite available treatments, managing emotional dysregulation in custody remains challenging, with youth often enduring high arousal, anger, and anxiety that persist into adulthood. Current popular therapies, including Cognitive Behavioral Therapy (CBT) and Dialectic Behavioral Therapy (DBT), often fall short in detention because they rely on verbal processing, require multiple scheduled sessions, and/or need highly trained staff. Other technologies, like biofeedback and neurostimulation techniques, are still under scrutiny for adolescents, given their higher-than-usual Adverse Events (AEs). This SoundHeal study aims to evaluate a sensory intervention using the Healpod, a distraction-free physical space where a participant sits, delivering sound, music, gentle vibrations, and ambient light. Following this is a brief expressive journaling exercise to compare any before, during and after experience changes from the sensory immersion. This prospective, single-center cohort study hypothesizes that these sessions will improve juveniles' ability to emotionally regulate, improve therapeutic alliance, mental health outcomes and build coping skills that can potentially help in long-term mental health and substance abuse treatment in JIY and beyond.

Recruiting
Has No Placebo

San Luis Obispo County Juvenile Hall

Nishat Bhuiyan, PhD

SoundHeal

Have you considered Equanil clinical trials?

We made a collection of clinical trials featuring Equanil, we think they might fit your search criteria.
Go to Trials

Have you considered Equanil clinical trials?

We made a collection of clinical trials featuring Equanil, we think they might fit your search criteria.
Go to Trials
Image of Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton in Hamilton, Canada.

Mindfulness for Postpartum Anxiety

18+
Female
Hamilton, Canada

Postpartum anxiety (PPA) affects up to 20% of mothers in the first year after delivery, with mothers often reporting both psychological and physical symptoms. Present non-pharmacological interventions are effective at improving some psychological aspects of PPA such as anxiety, depressive mood, and distress. However, current interventions are not effective in improving emotion regulation (ER), something that many with PPA experience impairment in. Current interventions also seldom target the physical aspects of anxiety, such as bodily awareness - sensing and understanding internal signals in the body (e.g., sensing a fast heartbeat). There is a link between ER and bodily awareness, however psychological interventions that target both these aspects have not been investigated in the PPA population. As a result, a mind-body intervention targeting both ER and bodily awareness is needed to offer a more holistic treatment option. The purpose of the proposed study is to test the effectiveness of a 4-week mindfulness intervention on anxiety symptoms, ER, and bodily awareness in those with PPA. We will use self-report questionnaires alongside brain imaging (functional magnetic resonance imaging; fMRI) to evaluate the effectiveness. Combining both subjective and objective measures will provide greater confidence in our findings, ensuring a more comprehensive understanding of the intervention's impact. Self-report questionnaires will be administered at enrolment, immediately post-intervention, and 4 weeks post-intervention. Brain imaging will be conducted at enrolment and immediately post-intervention. We believe this intervention will lead to improvements in anxiety symptoms, ER, and bodily awareness on the questionnaires and fMRI scans. If effective, the proposed mindfulness intervention will target a broader range of psychological and physical symptoms, and reduce the negative impact of PPA on mothers and their infants in Canada and beyond.

Recruiting
Has No Placebo

Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton (+1 Sites)

Sheryl M Green, Ph.D., C.Psych

Have you considered Equanil clinical trials?

We made a collection of clinical trials featuring Equanil, we think they might fit your search criteria.
Go to Trials